Longitudinal analysis of ocular disease in children with Mucopolysaccharidosis I after hematopoietic cell transplantation.

[1]  D. Mutti,et al.  Ocular Component Development during Infancy and Early Childhood. , 2018, Optometry and vision science : official publication of the American Academy of Optometry.

[2]  E. Chen,et al.  Children with mucopolysaccharidosis risk progressive visual dysfunction despite haematopoietic stem cell transplants , 2018, Acta paediatrica.

[3]  J. van Doorn,et al.  Salivary α-Iduronidase Activity as a Potential New Biomarker for the Diagnosis and Monitoring the Effect of Therapy in Mucopolysaccharidosis Type I. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  T. Aslam,et al.  The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler) , 2018, Acta ophthalmologica.

[5]  J. Eisengart,et al.  Long-term outcomes of systemic therapies for Hurler syndrome: an international multi-center comparison , 2018, Genetics in Medicine.

[6]  P. Veys,et al.  Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. , 2017, Blood advances.

[7]  P. Szodoray,et al.  Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis , 2017, Annals of clinical biochemistry.

[8]  T. Aslam,et al.  Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis. , 2017, Investigative ophthalmology & visual science.

[9]  V. Lee,et al.  Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis-A Ten-Year Report from the China Children Transplant Group. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  C. Summers,et al.  Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspective , 2016, British Journal of Ophthalmology.

[11]  J. Tolar,et al.  A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome. , 2016, Experimental eye research.

[12]  J. Kurtzberg,et al.  AAV Gene Therapy for MPS1-associated Corneal Blindness , 2016, Scientific Reports.

[13]  H. van Lenthe,et al.  A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses , 2015, PloS one.

[14]  A. T. van der Ploeg,et al.  Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  A. Fischer,et al.  Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. , 2015, Blood.

[16]  A. Fischer,et al.  Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. , 2013, Blood.

[17]  C. Summers,et al.  Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis , 2012, Acta ophthalmologica.

[18]  E. Chen,et al.  Corneal hysteresis in mucopolysaccharidosis I and VI , 2012, Acta ophthalmologica.

[19]  B. Pierscionek,et al.  Age variations in intraocular pressure in a cohort of healthy Austrian school children , 2012, Eye.

[20]  M. Repka,et al.  Central corneal thickness in children. , 2011, Archives of ophthalmology.

[21]  L. el Matri,et al.  Pediatric penetrating keratoplasty: indications and outcomes. , 2011, Transplantation proceedings.

[22]  C. Summers,et al.  Systemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy – a review , 2010 .

[23]  O. Oner,et al.  Central corneal thickness in children with diabetes. , 2009, Journal of refractive surgery.

[24]  J. Kurtzberg,et al.  Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  S. Biswas,et al.  Mucopolysaccharidoses and the eye. , 2006, Survey of ophthalmology.

[26]  N. Chamoles,et al.  Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper. , 2001, Clinical chemistry.

[27]  R. Hansen,et al.  Cycloplegic refractions in healthy children aged 1 through 48 months. , 2001, Archives of ophthalmology.

[28]  W. Petroll,et al.  Corneal stromal wound healing in refractive surgery: the role of myofibroblasts , 1999, Progress in Retinal and Eye Research.

[29]  J. Koretz,et al.  The development and maintenance of emmetropia , 1999, Eye.

[30]  C. Summers,et al.  Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up. , 1998, Ophthalmology.

[31]  T. Møller-Pedersen,et al.  Confocal microscopic characterization of wound repair after photorefractive keratectomy. , 1998, Investigative ophthalmology & visual science.

[32]  A. Vellodi,et al.  Ultrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patient. , 1996, Experimental eye research.

[33]  J. Hassell,et al.  Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.

[34]  G. Constantopoulos,et al.  Corneal opacity in canine MPS I. Changes after bone marrow transplantation. , 1989, Investigative ophthalmology & visual science.

[35]  M S Borcherding,et al.  Proteoglycans and collagen fibre organization in human corneoscleral tissue. , 1975, Experimental eye research.